These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1677735)

  • 1. Anti-GOR to screen HCV-RNA-positive blood donors.
    Watanabe J; Matumoto C; Nishioka K; Yoshizawa H
    Lancet; 1991 Aug; 338(8763):391. PubMed ID: 1677735
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus blood donor screening: recombinant immunoblot assay interpretation re-examined.
    Perrons CJ; Garson JA
    Vox Sang; 1993; 64(4):253. PubMed ID: 7685973
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HCV antibodies and HCV RNA in Libyan blood donors.
    Elzouki AN; Beeching NJ; Mutton KJ; Garson JA
    Vox Sang; 1995; 68(1):65. PubMed ID: 7536992
    [No Abstract]   [Full Text] [Related]  

  • 4. Routine screening of blood donations for HCV RNA.
    Araújo FM; Koch MC; Henriques I; Monteiro F; Araújo AR; Cunha-Ribeiro LM
    Vox Sang; 1998; 74(3):211. PubMed ID: 9595655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
    Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
    Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The diagnostic value of anti-HCV test in HCV infection].
    Liu FH; Tian GS; Fu XX
    Zhonghua Nei Ke Za Zhi; 1994 Apr; 33(4):229-31. PubMed ID: 7525166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HCV genotypes in Polish blood donors in period 1995-2007].
    Brojer E; Grabarczyk P; Kopacz A; Potepa A; Medyńska J; Smolarczyk-Wodzyńska J; Letowska M
    Przegl Epidemiol; 2008; 62(1):163-9. PubMed ID: 18536240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
    Schmidt M; Weber M; Busch MP; Tobler LH; Phelps BH; Seifried E; Roth WK
    Transfusion; 2005 Jun; 45(6):1040-2. PubMed ID: 15935008
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-hepatitis C antibody screening at the Natal Blood Transfusion Service.
    Soni PN; Robson SC; Kirsch RE; Simjee AE
    S Afr Med J; 1993 Mar; 83(3):218. PubMed ID: 8390102
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
    Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
    Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C infection in liver transplant patients.
    McCaughan GW; Pau A; Parsons C; McGuinness PH; Gallagher ND; Sheil AG
    Transplant Proc; 1992 Oct; 24(5):2256. PubMed ID: 1384207
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C transmission associated with intravenous immunoglobulins.
    Nübling CM; Willkommen H; Löwer J
    Lancet; 1995 May; 345(8958):1174. PubMed ID: 7536875
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of hepatitis C RNA and serum alanine aminotransferase in hepatitis B and C seronegative healthy blood donors.
    Ali N; Moiz B; Moatter T; Ahmed S; Adil SN; Khurshid M
    Indian J Pathol Microbiol; 2010; 53(3):480-5. PubMed ID: 20699507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood donor screening for hepatitis C.
    Dusheiko GM
    S Afr Med J; 1993 Mar; 83(3):217-8. PubMed ID: 8390101
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reduction of the proportion of anti-HCV-positive donations].
    Quiles FJ; Sanz A; Cabanillas A; Sáenz P; Sánchez GM; Díaz F
    Sangre (Barc); 1992 Apr; 37(2):153-4. PubMed ID: 1320294
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P; Echevarría JM
    Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.